IP Library Granted Patent US 9,867,723
Granted Patent B2
US 9,867,723 · App. 15/083,529 · Granted Jan 16, 2018

Procedures for vascular occlusion

Inventors: Aaron Berez (Portola Valley, CA); Quang Quoc Tran (Atherton, CA)
A61F2/82A61B17/12118A61B17/12172A61F2/01A61F2/06A61F2/852A61F2/90A61F2/95A61M5/007A61M29/00A61B2017/1205A61F2002/011A61F2002/823A61F2002/826A61F2002/9528A61F2230/0078A61F2230/0091A61F2230/0095A61F2250/0018A61F2250/0026A61F2250/0065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,867,723
App. No.
15/083,529
Granted
Jan 16, 2018
Kind
B2
Abstract

A method of reducing blood flow within an aneurysm includes: injecting a contrast agent into a blood vessel including an aneurysm; deploying an occlusion device across the aneurysm; producing an image of the aneurysm including the contrast agent; and withdrawing the delivery device from the vessel after observing that the aneurysm has been stagnated by a desired amount. The image may be two-dimensional or three-dimensional. Observing that the aneurysm has been stagnated may include determining a degree of stagnation, for example by comparing an area or volume of the contrast agent in a first image and a second image. The desired amount may be a certain degree of stagnation, identification of a shape indicative of stasis such as a flat surface, an approximate hemisphere, a mushroom, or a crescent. If the occlusion device does not achieve the desired amount, a second occluding device may be deployed.

Claims (27)

1. A method of reducing blood flow within an aneurysm, the method comprising:

expanding a stent, from a delivery device, across the aneurysm, such that a stagnated area forms in the aneurysm;

injecting a contrast agent into a blood vessel comprising an aneurysm;

imaging the stagnated area; and

upon observing that the stagnated area occupies more than 30% and less than 70% of a body of the aneurysm, withdrawing the delivery device from the vessel.

2. The method of claim 1 , wherein, after withdrawing the delivery device, substantially all of the aneurysm progressively thromboses.

3. The method of claim 1 , wherein the imaging is sufficient to determine that the expanding the stent is sufficient to lead to thrombosis of the aneurysm.

4. The method of claim 1 , wherein the stent, when expanded, has a porosity that is configured to result in a delayed thrombosis of the aneurysm.

5. The method of claim 4 , wherein the porosity is between about 60% and about 85%.

6. The method of claim 1 , wherein the withdrawing is while the stagnated area occupies more than about 50% of the body of the aneurysm.

7. The method of claim 1 , wherein the imaging comprises comparing a first image of the aneurysm before expanding the stent to a second image of the aneurysm after expanding the stent.

8. The method of claim 1 , wherein withdrawing the delivery device from the vessel comprises releasing the stent from the delivery device.

9. The method of claim 1 , further comprising expanding a second stent across the aneurysm while the stagnated area does not occupy more than 30% and less than 70% of the body of the aneurysm.

10. A method of reducing blood flow within an aneurysm, the method comprising:

expanding a stent, from a delivery device, across the aneurysm, such that a stagnated area forms in the aneurysm;

injecting a contrast agent into a blood vessel comprising an aneurysm;

imaging the stagnated area; and

upon observing that the stagnated area occupies more than 20% and less than 100% of a body of the aneurysm, withdrawing the delivery device from the vessel.

11. The method of claim 10 , wherein, after withdrawing the delivery device, substantially all of the aneurysm progressively thromboses.

12. The method of claim 10 , wherein the imaging is sufficient to determine that the expanding the stent is sufficient to lead to thrombosis of the aneurysm.

13. The method of claim 10 , wherein the stent, when expanded, has a porosity that is configured to result in a delayed thrombosis of the aneurysm.

14. The method of claim 13 , wherein the porosity is between about 60% and about 85%.

15. The method of claim 10 , wherein the withdrawing is while the stagnated area occupies more than 50% of the body of the aneurysm.

16. The method of claim 10 , wherein the withdrawing is while the stagnated area occupies more than 70% of the body of the aneurysm.

17. The method of claim 10 , wherein the withdrawing is while the stagnated area occupies less than 90% of the body of the aneurysm.

18. The method of claim 10 , wherein the withdrawing is while the stagnated area occupies less than 70% of the body of the aneurysm.

19. The method of claim 10 , wherein the imaging comprises comparing a first image of the aneurysm before expanding the stent to a second image of the aneurysm after expanding the stent.

Assignments (5)
MERGER Recorded Oct 9, 2019
From: CHESTNUT MEDICAL TECHNOLOGIES, INC.
To: EV3 INC.
Reel/Frame 050665/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: EV3 LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 050665/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: BEREZ, AARON LEE; TRAN, QUANG QUOC
To: CHESTNUT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 050670/0156 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 050676/0380 →
CHANGE OF NAME Recorded Oct 9, 2019
From: EV3 INC.
To: EV3 LLC
Reel/Frame 051486/0422 →
Continuity (9)
Continuation 14791617 · Jul 6, 2015
Continuation 13652591 · Oct 16, 2012
Continuation 12751997 · Mar 31, 2010
Continuation 15083529
Continuation In Part 14885576 · Oct 16, 2015
Continuation 14026510 · Sep 13, 2013
Continuation 12490285 · Jun 23, 2009
Provisional Application 61288525 · Dec 21, 2009
Related Publication 20160278908A1 · Sep 29, 2016